Charles River Laboratories International, Inc. (CRL) NYSE

168.92

+4.68(+2.85%)

Updated at February 20 04:00PM

Currency In USD

Valuation

Market Cap10.09B
Enterprise Value12.95B
P/E Ratio-57.6
PEG Ratio0.64
Price/Sales Ratio2.07
Price/Book Ratio2.63
Enterprise/Revenue2.78
Enterprise/EBITDA13.93

Fiscal Year

Fiscal YearDecember 27, 2025
Most Recent QuarterDecember 27, 2025

Profitability

Profit Margin-0.04
Operating Margin0.11

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.04

Income Statement

Revenue4.02B
Revenue/Share81.59
Gross Profit1.23B
EBITDA911.15M
Net Income-144.34M
Diluted EPS-2.91

Balance Sheet

Total Cash213.77M
Total Cash/Share4.34
Total Debt3.07B
Total Debt/Equity0.97
Current Ratio1.29
Book Value Per Share65.25

Price History

52-Week Change3.62
52-Week High228.88
52-Week Low91.86
Moving Average 50 Days201.9
Moving Average 200 Days169.28

Statistics

Average Volume800,170
Shares Outstanding49.22M
% Held by Institutions82.96

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A